BioXcel Therapeutics prices 5.6M shares at 48c in public offering

1 day ago · BioXcel Therapeutics (BTAI) announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 per share and accompanying …

CouponFollow Extension

$0.00
OFF

BioXcel Therapeutics Prices 5.6M Shares At 48c In Public Offering

6 days from now

1 day ago · BioXcel Therapeutics (BTAI) announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 per share and accompanying …

businessinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence …

bioxceltherapeutics.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

22 hours ago · Each of the accompanying warrants will have an exercise price of $0.48 per underlying share of Common Stock. Canaccord Genuity is acting as sole book-running …

yahoo.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

21 hours ago · BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript; BioXcel announces common stock and warrants offering, no amount given; BioXcel Therapeutics …

seekingalpha.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7M Public Offering

6 days from now

BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript; BioXcel announces common stock and warrants offering, no amount given; BioXcel Therapeutics GAAP EPS of -$0.32 …

msn.com

$9
OFF

BioXcel Therapeutics Announces Proposed Public Offering

6 days from now

Feb 8, 2024 · In addition, the Company expects to grant the underwriters a 30-day option to purchase up to $9.0 million of additional shares of common stock at the public offering price, …

yahoo.com

$214000
OFF

BioXcel Therapeutics Reports Q3 EPS (32c), Consensus (48c)

6 days from now

Nov 14, 2024 · Reports Q3 revenue $214,000, consensus $1.33M. “Our focus continues to be the clinical development of BXCL501,” said Vimal Mehta, Ph.D., CEO of BioXcel Therapeutics …

nasdaq.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million

6 days from now

22 hours ago · Each of the accompanying warrants will have an exercise price of $0.48 per underlying share of Common Stock. Canaccord Genuity is acting as sole book-running …

globenewswire.com

$60
OFF

BioXcel Therapeutics Commences $60 Mln Public Offering; Stock …

6 days from now

Feb 8, 2024 · (RTTNews) - BioXcel Therapeutics Inc. (BTAI) said that it has commenced an underwritten public offering of $60.0 million of shares of its common stock or, in lieu of …

businessinsider.com

$7
OFF

BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …

6 days from now

1 day ago · Each of the accompanying warrants will have an exercise price of $0.48 per underlying share of Common Stock. Canaccord Genuity is acting as sole book-running …

stockhouse.com

$9
OFF

BioXcel Therapeutics Announces Proposed Public Offering

6 days from now

Aug 2, 2024 · In addition, the Company expects to grant the underwriters a 30-day option to purchase up to $9.0 million of additional shares of common stock at the public offering price, …

globenewswire.com

$7
OFF

BioXcel Therapeutics Prices $7M Public Offering Of 5.6M Shares …

6 days from now

1 day ago · Including Pre-Funded Warrants For Up To 9M Shares, BioXcel Therapeutics Prices $7M Public Offering Of 5.6M Shares And Warrants At $0.48 Per Unit; With Proceeds …

sahmcapital.com

$60
OFF

BioXcel Therapeutics Terminates $60 Mln Proposed Public Offering

6 days from now

Feb 13, 2024 · (RTTNews) - Tuesday, BioXcel Therapeutics, Inc. (BTAI) announced the termination of its proposed public offering of $60 million in common stock which was …

businessinsider.com

$0.58
OFF

BioXcel Therapeutics Stock Price - Markets Insider

6 days from now

On Wednesday 11/20/2024 the closing price of the BioXcel Therapeutics Inc Registered Shs share was $0.58 on BTT. Compared to the opening price on Wednesday 11/20/2024 on BTT …

businessinsider.com

FAQs about BioXcel Therapeutics prices 5.6M shares at 48c in public offering Coupon?

Does bioxcel Therapeutics (btai) have a public offering?

(RTTNews) - BioXcel Therapeutics Inc. (BTAI) said that it has commenced an underwritten public offering of $60.0 million of shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. BTAI closed Thursday's regular trading at $3.75 down $0.03 or 0.79%. ...

Who owns bioxcel Therapeutics?

Private Companies own 31% of the shares in BioXcel Therapeutics, Inc. (NASDAQ:BTAI). The general public holds a 24% stake in the company, but they may not have enough influence to sway policy decisions. ...

How much did bioxcel Therapeutics raise in an IPO?

BioXcel Therapeutics (BTAI) raised $60 million in their IPO on Thursday, March 8th 2018. The company issued 5,000,000 shares at a price of $11.00-$13.00 per share. $60 million was raised in the IPO. ...

Is BioXcel Therapeutics a risky stock?

BioXcel Therapeutics is a risky stock despite its massive potential upside. Biotech companies rarely win every clinical or regulatory battle they face, and if the company fails in even one important aspect, its shares will likely plunge. Only those investors comfortable with this risk should consider initiating a position. ...

What was the closing price of bioxcel Therapeutics Inc registered SHS?

On Thursday 08/22/2024 the closing price of the BioXcel Therapeutics Inc Registered Shs share was $0.65 on BTT. Compared to the opening price on Thursday 08/22/2024 on BTT of $0.67, this is a drop of 2.47%. BioXcel Therapeutics Inc Registered Shs's market capitalization is $27.14 M by 40.74 M shares outstanding. ...

What is the price target for bioxcel Therapeutics Inc registered SHS (BTT)?

Compared to the opening price on Thursday 08/22/2024 on BTT of $0.67, this is a drop of 2.47%. BioXcel Therapeutics Inc Registered Shs's market capitalization is $27.14 M by 40.74 M shares outstanding. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Selling, General & Admin. Exp. ...